Moderna | MRNA - Current Liabilities

Stock Price
49.06
Daily Change
-0.97 -1.94%
Monthly
-10.28%
Yearly
97.35%
Q2 Forecast
53.22

Moderna reported $2.4B in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Acadia Pharmaceuticals USD 305.52M 28.41M Mar/2026
Agios Pharmaceuticals USD 58.84M 23.36M Mar/2026
Alnylam Pharmaceuticals USD 1.35B 116.87M Mar/2026
Amgen USD 24.96B 534M Mar/2026
Arrowhead Research USD 295.22M 52.2M Mar/2026
Biogen USD 3B 350.5M Mar/2026
BioMarin Pharmaceutical USD 793.15M 34.12M Mar/2026
Celltrion KRW 283.62B 3.72T Dec/2025
Cspc Pharmaceutical CNY 10.18B 65.36M Dec/2025
Deva Holding AS TRY 6.43B 1.18B Sep/2023
Dianthus Therapeutics USD 38.28M 7.55M Mar/2026
Divis Laboratories Ltd INR 17.28B 2.76B Sep/2025
Esperion Therapeutics USD 300.36M 451K Mar/2026
Gilead Sciences USD 9.48B 2.34B Mar/2026
GlaxoSmithKline GBP 22.43B 1.04B Mar/2026
Incyte USD 1.49B 25.52M Mar/2026
Ionis Pharmaceuticals USD 717M 66M Mar/2026
Kangmei Pharma CNY 5.81B 57.93M Sep/2025
Knight Therapeutics CAD 165.26M 12.58M Dec/2025
Laboratorios Farma EUR 199.84M 121.75M Dec/2023
Malin Corporation EUR 1000K 500K Dec/2024
Moderna USD 2.4B 408M Mar/2026
Organigram Holdings CAD 94.05M 32.11M Dec/2025
Ovoca Bio EUR 186K 2.26M Jun/2025
Pharma Mar EUR 89.23M 4.65M Mar/2026
Puma Biotechnology USD 82.73M 3.63M Sep/2025
Qiagen NV USD 512.14M 461.26M Dec/2025
Regeneron Pharmaceuticals USD 5.11B 739.3M Mar/2026
Sangamo BioSciences USD 47.66M 1.9M Jun/2025
Sarepta Therapeutics USD 499.16M 596.13M Mar/2026
Sartorius EUR 2.11B 145.8M Mar/2026
Sino Biopharmaceutical CNY 24.85B 5.29B Jun/2025
Tilray USD 259.32M 8.32M Sep/2025
Ultragenyx Pharmaceutical USD 325M 59M Mar/2026
United Therapeutics USD 599.1M 38.5M Mar/2026
Vertex Pharmaceuticals USD 3.88B 19.4M Mar/2026
Zealand Pharma A/S 664.96M 513.61M Dec/2025
Zz Pientze Pharmaceu CNY 2.28B 134.52M Mar/2026